SEARCH

SEARCH BY CITATION

Summary

  1. Top of page
  2. Summary
  3. Introduction
  4. Phage display
  5. Cell surface display
  6. Endospores
  7. Magnetosomes
  8. PHA granules
  9. References

Proteins are often found attached to surfaces of self-assembling biological units such as whole microbial cells or subcellular structures, e.g. intracellular inclusions. In the last two decades surface proteins were identified that could serve as anchors for the display of foreign protein functions. Extensive protein engineering based on structure–function data enabled efficient display of technically and/or medically relevant protein functions. Small size, diversity of the anchor protein as well as support structure, genetic manipulability and controlled cultivation of phages, bacterial cells and yeasts contributed to the establishment of designed and specifically functionalized tools for applications as sensors, catalysis, biomedicine, vaccine development and library-based screening technologies. Traditionally, phage display is employed for library screening but applications in biomedicine and vaccine development are also perceived. For some diagnostic purposes phages are even too small in size so other carrier materials where needed and gave way for cell and yeast display. Only recently, intracellular inclusions such as magnetosomes, polyhydroxyalkanoate granules and lipid bodies were conceived as stable subcellular structures enabling the display of foreign protein functions and showing potential as specific and tailor-made devices for medical and biotechnological applications.


Introduction

  1. Top of page
  2. Summary
  3. Introduction
  4. Phage display
  5. Cell surface display
  6. Endospores
  7. Magnetosomes
  8. PHA granules
  9. References

The microbial cell surface localization of molecules engaged in, e.g. cell recognition, signal transduction, surface adherence, immunoreactions or movement and/or colonization is a frequently applied principle in nature. Steric effects often cause poor exposure of surface-displayed heterologous polypeptides resulting in low interaction of the displayed protein with antibodies, small molecules or ligands. Therefore, the fusion of the protein of interest to exposed natural surface proteins or appendages such as flagella or pili is a strategy to overcome these constraints and to allow increased exposure i.e. functionality of the displayed protein function. This review will focus on the different surface display systems investigated so far for phage, bacterial and yeast cell display, endospores, magnetosomes and polyhydroxyalkanoate (PHA) granules.

Phage display

  1. Top of page
  2. Summary
  3. Introduction
  4. Phage display
  5. Cell surface display
  6. Endospores
  7. Magnetosomes
  8. PHA granules
  9. References

Phage display can be regarded as one of the first extensively developed and utilized foreign protein display systems harnessing the prolific self-assembling process of the bacteriophage and its defined surface protein architecture (Smith, 1985; Gao et al., 2010; Rakonjac et al., 2010). Most widely used is Escherichia coli phage M13 but also λ and T7 (Benhar, 2001). Affinity screening of phage display libraries is also called ‘biopanning’ (Parmley and Smith, 1988). In several rounds of panning the engineered phage particles are incubated with the ligand of interest, which is immobilized on a solid support material. Several washes are performed to exclude unspecific binding, followed by elution of the bound particles (Rakonjac et al., 2010). Phage display systems are especially applied to combinatorial approaches and are the main tool for the isolation and engineering of recombinant antibodies (Benhar, 2001). Recombinant antibody display started with the fusion of the variable region of a single-chain antibody (scFv) fragment to the amino terminus of the phage minor coat protein III (McCaffterty et al., 1990). A following successful application has been the isolation of monoclonal antibodies using phage display and library screening (Winter et al., 1994). In recent years techniques were optimized allowing now design and construction of large libraries of screening targets but especially antibodies (Hoogenboom et al., 1998). For most phages purification is easy and large-scale production is inexpensive; therefore, phage display has also been considered for protein or antibody purification (Clark and March, 2006). Phage display is a very versatile technology, e.g. a treatment against cocaine addiction is based on phage display technology. Nasally delivered whole phage particles displaying a specific cocaine-sequestering antibody can enter the central nervous system and bind to cocaine molecules, thus inhibiting their action on the brain (Dickerson et al., 2005).

One of the main characteristics of bacteriophages is their specificity for the bacterial host. Using this natural affinity, phages have been used for the detection and genotyping of bacteria. Either, the bacteria-bound phages were detected with labelled antibodies, thereby increasing the detection sensitivity (Watson and Eveland, 1965) or the phages were already labelled with the fluorescent dye covalently attached to the coat proteins (Goodridge et al., 1999). Also, phages are specifically employed to deliver reporter genes, encoding fluorescent proteins such as luciferase or the green fluorescent protein (GFP), which are expressed after the infection of the specific host bacteria (Kodikara et al., 1991; Funatsu et al., 2002).

Bacteriophages are also investigated as new vaccines. As bacteriophages are not able to replicate in eukaryotic hosts they are seen as inert antigens and processed by antigen-presenting cells (Gaubin et al., 2003; Gao et al., 2010). As one of the first examples, the protective epitope 173–187 from the glycoprotein G of the human respiratory syncytial virus was fused to the fd phage pIII coat protein. The heterologous protein was displayed at the phage surface and the recombinant phage particles were used to immunize mice. These immunogenic peptide presenting phage particles could be applied as vaccine and conferred a protective immune response. Immunized mice were challenged but the phage vaccine prevented an infection of the immunized animals by the pathogen (Bastien et al., 1997). For vaccination purposes the oral application route seemed more favourable but results varied regarding survival of phage vaccines in gastric fluid, which was also depending on the chosen anchoring motif and on whether purified proteins or whole phage particles were used (Zuercher et al., 2000). Generally, epitope displaying phage particles can induce a specific antibody response when applied orally (Benhar, 2001) and a study involving human volunteers demonstrated the safety of an oral application of phages (Bruttin and Brussow, 2005).

The disadvantage of the smallness of the phage particles is the incompatibility with fluorescence activated cell sorting (FACS) technology (Francisco and Georgiou, 1994). Nevertheless, phage display is a useful tool in biomedical applications and can potentially be used for imaging and diagnosis of tumours and cancerous cell aggregates. Phage display is a potent technique, which permits the screening of vast sequences, can be employed for peptide affinity improvement and generation of unique binding peptides (Deutscher, 2010).

Virus-like particles (VLPs)

Virus-like particles are composed of viral capsid proteins that show the intrinsic ability to spontaneously self-assemble after expression. VLPs can be isolated after recombinant coat protein expression or assembled in vitro from purified, recombinantly expressed coat protein subunits. VLPs can be expressed in a wide variety of hosts, ranging from bacterial to mammalian cells (Garcea and Gissmann, 2004). Capsid proteins display basic domains facing the inside of the particle and are therefore predestined to bind nucleic acids via stable, non-specific ionic interactions. Similarly, small molecules with the appropriate ion charge can be internalized by VLPs. Inclusion of nucleic acid or small molecules can be triggered by an ‘osmotic shock’ reaction, where dilution into low ionic strength solution is causing increased spaces between the coat protein subunits and the interior positive charges are pulling the nucleic acid or other molecules to the inside (Barr et al., 1979). Incorporation can also occur during in vitro assembly of coat proteins in the presence of nucleic acids (Braun et al., 1999; Henke et al., 2000). The best characterized models for the generation and application of VLPs are papilloma and polyoma virus (Petry et al., 2003). The polyoma VP1 coat protein was engineered to display the IgG binding domain Z from Staphylococcus aureus in its H1 loop (Gleiter and Lilie, 2001; May et al., 2002). The generated chimeric proteins were still able to self-assemble as well as to bind DNA. A plasmid encoding GFP was incorporated into the engineered VLPs and an antibody directed against the cell-surface receptor ErbB2 was bound to the surface displayed Z domain. The VLPs were specifically targeted to ErbB2 receptor displaying cells where after incubation GFP fluorescence could be observed (Gleiter and Lilie, 2003). The main application of VLPs is the development of new, effective, fast and inexpensive vaccines. VLPs are very immunogenic and interact very well with dendritic cells and other antigen presenting cells (Lenz et al., 2001; Rudolf et al., 2001; Warfield et al., 2003). One already approved VLP vaccine is used for immunization against human papilloma virus 16. It is composed of the major structural protein L1 and is able to induce a high titre of neutralizing antibodies and confers protection against human papilloma virus infection (Koutsky et al., 2002). Recently, researchers are focussing on the development of an efficient and rapidly prepared influenza vaccine. Current influenza vaccine development is time-consuming and limited to chicken egg production whereas influenza-VLPs could be rapidly prepared as soon as the targeted influenza virus RNA is isolated (Szécsi et al., 2006). It has been proven successful to display three to four of the major antigens of various influenza viruses on the VLPs to induce a broad array of immunity and confer a protection against influenza challenges (Bright et al., 2008; Ross et al., 2009; Wu et al., 2010) (Table 1).

Table 1.  Examples for different surface display systems.
Display systemAnchorFunctionApplicationReferences
AnchorFusion partner
PhagepIIIM13 coat proteinscFvAntibody engineeringMcCaffterty et al. (1990)
EpitopesVaccinesBastien et al. (1997)
pVIIIM13 coat proteinPeptides/antibodiesLibrary screeningBenhar (2001)
Virus-like particlesVP1Polyoma virus coatZ domain of protein AAntibody purificationGleiter and Lilie (2001)
L1Human papilloma virusVaccineKoutsky et al. (2002)
Gram-negative cellsLamBMaltoporinPeptidesLibrary screeningBenhar (2001)
OmpAOuter membrane proteinPeptidesLibrary screeningBenhar (2001)
Lpp-OmpALipoprotein/OmpA chimereEnzymes/antibodiesBiosensorsChen and Georgiou (2002)
INPIce nucleation proteinEnzymesBiosensorsLi et al. (2003)
FliCFlagellae protein (flagellin)Peptides/antigensLibrary screeningLu et al. (1995)
FimAFimbriae protein (fimbrillin)Epitopes/antigensVaccinesSamuelson et al. (2002)
Bacterial ghosts E. coli O157:H7 antigens VaccinesMayr et al. (2005)
 Vibrio cholerae antigens VaccinesEko et al. (2003b)
L′DNA-binding protein of MS2DNADNA vaccineMayrhofer et al. (2005)
Gram-positive cellsProtein ACell wall anchor (covalent)StreptavidinBiotin-bindingSteidler et al. (1998)
Metal binding peptidesBioremediationSamuelson et al. (2000)
LysMCell wall anchor (non-covalent)GFP/laccaseEnzyme displayShao et al. (2009)
FnBPBFibronectin-binding proteinLipase/lactamaseBioassaysStrauss and Götz (1996)
M6Cell wall bindingCohesinsEnzyme displayWieczorek and Martin (2010)
S-layersSbpALysinibacillus sphaericusBet v1VaccinesIlk et al. (2011)
RsaACaulobacter crescentusProtein GAntibody bindingNomellini et al. (2007)
YeastAgα1α-agglutininZ domain of protein AImmunoassaysShimojo et al. (2004)
Aga1/Aga2a-agglutininWasp venom antigensVaccinesBorodina et al. (2010)
CohesinsBiofuel productionWen et al. (2010)
Flo1FlocculinLipaseEnzyme displayMatsumoto et al. (2002)
EndosporesCotB, C, DCoat proteinsToxins/antigensVaccinesIsticato et al. (2001)
Mauriello et al. (2004)
Duc et al. (2007)
MagnetosomesMms13Transmembrane proteinProtein A/GIgG purificationMatsunaga et al. (2006)
PHA beadsPhaFPhasinEnzymesProtein purificationMoldes et al. (2004)
PhaPPhasinEnzymesProtein purificationBanki and Wood (2005)
PhaZDepolymeraseFluorophoresProtein purificationLee et al. (2005)
PhaRRegulatorGFPProtein purificationZhang et al. (2010)
PhaCSynthaseProtein A/enzymesBioassaysGrage et al. (2009)
  AntigensVaccinesParlane et al. (2009)
Lipid bodiesPhaP1PhasinEnzymesEnzyme displayHänisch et al. (2006b)
LD domainEukaryotic binding proteinGFPIn vivo monitoringYu et al. (2011)

Cell surface display

  1. Top of page
  2. Summary
  3. Introduction
  4. Phage display
  5. Cell surface display
  6. Endospores
  7. Magnetosomes
  8. PHA granules
  9. References

Gram-negative bacterial cell display

In 1986 the first reports about bacterial display of foreign peptides/proteins were published and gave way to new insights, developments and applications of bacterial cells (Charbit et al., 1986; Freudl et al., 1986). In the following decades, applications such as vaccine delivery vehicles, library and selection devices, cellular adsorbents and biocatalysts were described (Ståhl and Uhlén, 1997). The first used outer membrane proteins LamB (maltoporin), OmpA (outer membrane protein A) and PhoE (phosphate-inducible porin) were not applicable for the display of larger proteins (Benhar, 2001). Appendices like flagellae and fimbriae were presented as alternatives for the surface display of proteins and also offered the possibility to overcome steric hindrances occurring in the outer membrane. Flagellae are mainly composed of the major flagellin protein FliC (Wilson and Beveridge, 1993). The N- and C-terminal regions of FliC are highly conserved, whereas the central region is variable and not essential for the filament structure (Wilson and Beveridge, 1993) and therefore employed for the display of foreign polypeptides and proteins. The first example was the successful surface display of a hen egg-white lysozyme epitope within FliC (Kuwajima et al., 1988). Various proteins have been displayed using this technique, also thioredoxin that was used for library display and protein–protein interactions studies (Lu et al., 1995). Fimbriae are long filamentous adhesins required for targeting and colonization of specific host regions and mainly consist of the major subunit fimbrillin. The hypervariable regions of this protein are potential insertion points for the display of foreign epitopes and antigens (Samuelson et al., 2002). Georgiou and co-workers developed a very robust and widely applied display system based on the lipoprotein Lpp and the outer membrane protein OmpA. The first nine residues of the Lpp signal peptide are fused to the residues 46–159 of OmpA and thus allow surface display of a protein fused to the C terminus of the anchoring chimera (Francisco et al., 1992). This system allowed the display of full-length proteins on the surface of E. coli. Proteins such as cellulases, esterases, organophosphate hydrolases, scFv antibodies/enzymes, β-lactamase or thioredoxin have been successfully displayed using the Lpp-OmpA system (Chen and Georgiou, 2002). Recently, a different display system utilizing the ice nucleation protein (INP) from Pseudomonas syringae has been developed (Jung et al., 1998). The N-terminal region anchors in the membrane via glycosylphosphatidylinositol (GPI). INP can be used as full-length anchor, but more frequently either only the N-terminal region or a fusion of N- and C-terminus are used. Some results suggested the addition of the C-terminal domain might stabilize the fusion protein, depending on the fusion partner. For example, the production of GFP was unaffected by addition of the C-terminal domain, whereas organophosphorus hydrolase production and activity was significantly enhanced (Li et al., 2003). The INP system could also be established in Pseudomonas putida (Jung et al., 2006). A second INP system is based on the INP from P. syringae INA5. It is employed the same way as the previously described system based on InaK. Compared with Lpp-OmpA and InaK as anchors, the InaV system led to five times higher activity of the fusion partner organophosphorus hydrolase. Also, no lysis or growth inhibition of the host could be detected as compared with using Lpp-OmpA (Shimazu et al., 2001).

A display system with broader versatility might be the use of bacterial autotransporters. The natural occurring passenger domain can be replaced by a heterologous protein to be displayed on the cell surface. As autotransporters are widely distributed and show high homology among Gram-negative bacteria, one construct could be applied in several hosts (Rutherford and Mourez, 2006).

Bacterial ghost based delivery and display

Bacterial ghosts are non-living, empty cell envelopes of Gram-negative bacteria origin. These empty shells are the result of the expression of the bacteriophage ΦX174 and the resulting protein E-mediated cell lysis (Lubitz et al., 1984; Witte et al., 1990). The protein E-derived lysis is leading to the formation of a specific transmembrane tunnel structure. Due to the osmotic pressure difference, the cytoplasmic content is banished and empty bacterial cell envelopes can be retrieved (Blasi et al., 1989; Witte et al., 1992). Additionally, a staphylococcal nuclease is employed to degrade host and plasmid DNA (Haidinger et al., 2003). Therefore, bacterial ghosts are safe as no pathogenic islands or antibiotic resistances can be transferred by horizontal gene transfer (Lubitz et al., 2009). The bacterial ghosts exhibit the natural non-denatured surface components of the original Gram-negative bacterial cells with all targeting functions and can be applied for foreign protein display as described for genetically active Gram-negative bacterial cells (Eko et al., 2000). Most commonly, bacterial ghosts are applied as vaccines or gene delivery vehicles (Jalava et al., 2002). The lipopolysaccharides (LPS) of the bacterial ghosts are not limiting their use and application as candidate vaccines as no significant fever responses due to the endotoxins could be observed (Mader et al., 1997). Due to the intact outer membrane, bacterial ghosts are recognized by the innate immune system. They are ingested by dendritic cells and macrophages and are able to generate cellular and humoral immune responses without exogenous adjuvants (Haslberger et al., 2000; Jalava et al., 2003). Bacterial ghost vaccine preparations are stable for many years at ambient temperatures as they are freeze-dried and therefore do not require a cold chain storage system (Szostak et al., 1996). A simple but effective application is the use of bacterial ghosts as candidate vaccines against pathogenic Gram-negative bacteria. Ghosts of the enterohaemorrhagic strain E. coli O157 : H7 have been prepared and applied in a mouse model. A single dose of the orally applied vaccine was sufficient to induce protection even against a lethal challenge (Mayr et al., 2005). Same results could be observed with intragastric immunization of mice where the mixed immune response was dominated by humoral immunity (Cai et al., 2010). Rabbits orally vaccinated with Vibrio cholerae ghosts also showed protection against lethal challenge (Eko et al., 2003b). Also, V. cholerae ghosts engineered to display Chlamydia trachomatis antigens induced a Th1 response specific to Chlamydia infection (Eko et al., 2003a). Bacterial ghosts are also applied as DNA vaccines. The antigen-encoding plasmid DNA can be loaded in vitro in the bacterial ghost structures as shown with E. coli and Pasteurella haemolytica ghosts, loaded with plasmids encoding GFP (Ebensen et al., 2004; Paukner et al., 2005). The loaded DNA was localized to the inner lumen of the ghosts as shown with confocal laser scanning microscopy to exclude outer surface association of the DNA. Green fluorescence could be observed in macrophages and dendritic cells, proving the efficient targeting and gene transfer of the loaded bacterial ghosts. Murine vaccination studies revealed a modulation of the immune response from a mixed Th1/Th2 to a more dominant Th2 pattern (Ebensen et al., 2004). More sophisticated is the in vivo loading of the ghost particles by using the so-called self-immobilizing plasmid system (pSIP) (Jechlinger et al., 2004). A DNA binding protein anchored to the inner membrane is interacting with the corresponding operator region on the in vivo loaded plasmid DNA. By interaction of the different proteins, the loaded DNA is protected from the nuclease in the ghost generating step. After transfection and induction the operon repressor is released and the target gene expressed (Mayrhofer et al., 2005). This system allows for a one-step process of bacterial ghost generation and DNA loading.

Gram-positive bacterial cell display

Escherichia coli is the most frequently employed host organism for bacterial cell surface display and although most genetic engineering tools and techniques are designed for this organism, Gram-negative bacteria also have disadvantages, e.g. transport over two membranes or LPS-toxicity. In recent years much progress was made especially overcoming low transformation efficiencies with Gram-positive host bacteria and therefore it became feasible to also employ ‘generally regarded as safe’ (GRAS) organisms for biomedical applications. The most frequently used display system in Gram-positive bacteria is engaging the cell wall binding ability of protein A from S. aureus (Schneewind et al., 1995). The protein A cell wall sorting signal comprises a LPXTG sequence motif followed by a stretch of hydrophobic membrane-spanning residues and six or seven mostly positively charged amino acid residues at the extreme C terminus serving as retention signal to prevent the secretion of the protein into the surrounding medium (Schneewind et al., 1993). A transpeptidase (sortase) recognizes the LPXTG motif and catalyses the covalent anchoring of protein A to the cell wall. This anchoring mechanism can be conferred to several Gram-positive host organisms. For example Lactococcus lactis and was employed for the functional display of streptavidin monomer (Steidler et al., 1998). This system was also utilized for the first use of a Gram-positive host –Staphylococcus carnosus– for library screening and selection of affinity proteins (Kronqvist et al., 2008). Gram-positive bacteria are also considered for application as biosorbents in bioremediation of heavy metals. Therefore, especially staphylococci are engineered to display metal-binding motifs as fusions with the protein A cell wall anchor, e.g. polyhistidyl residues or cellulose-binding domains engineered to bind divalent ions such as Ni2+ were successfully displayed (Samuelson et al., 2000; Wernérus et al., 2001). The lysine motif domain LysM can be used for non-covalent cell wall binding and exposure of a heterologous fusion protein. (Shao et al., 2009) developed a display system for Bacillus thuringiensis using the LysM domain of a peptidoglycan hydrolase and GFP as well as a laccase as reporter. Also, the C-terminal region of the S. aureus fibronectin-binding protein B (FnBPB) was N-terminally functionalized for the display of a lipase or β-lactamase in S. carnosus. The FnBPB variant contained the original cell wall sorting signal and cell wall spanning region and was sufficient for the functional immobilization of normally soluble enzymes without influencing their catalytic activity (Strauss and Götz, 1996). The streptococcal M6 protein was used as anchor to C-terminally displayed cohesin modules and thus a complex of enzymes similar to cellulosomes on the surface of L. lactis exploiting the cohesin-dockerin system was established. These authors envisaged the display of multiple enzymes on the same cell surface applying their system with the corresponding number of cohesin scaffolds on a single cell wall anchor (Wieczorek and Martin, 2010).

S-layers

S-layers are crystalline arrays of protein and glycoprotein subunits and are widely distributed among all phylogenetic branches of Archaea and Bacteria (Engelhardt and Peters, 1998; Sleytr and Beveridge, 1999). The individual subunits are linked to each other as well as to the cell wall peptidoglycan in Gram-positive bacteria or the LPS of the outer membrane of Gram-negative bacteria by non-covalent forces (Sleytr and Beveridge, 1999). S-layer proteins are assembled in a two-dimensional lattice with oblique, tetragonal or hexagonal symmetry (Mobili et al., 2010). In most species S-layers are monomolecular and consist of only one type of protein, in some such as Clostridium difficile two different proteins derived from the same precursor assemble to the S-layer structure (Calabi et al., 2001). Several specific functions are assigned to the individual surface layers, e.g. protective coats, molecular sieves, molecule and ion traps, cell adhesion, surface recognition or virulence factors (Mobili et al., 2010). One of the most remarkable and biotechnological exploited property of S-layer proteins is the ability to self-assemble in suspension (Sleytr et al., 2007a,b). For biotechnological approaches natural S-layer hosts are employed but S-layer comprising fusion proteins are also recombinantly expressed, e.g. in Bacillus subtilis, which is GRAS approved but has no intrinsic S-layer on its cell surface (Fu et al., 2006). The most commonly employed S-layer protein from a Gram-positive is SbpA of Lysinibacillus sphaericus CCM2177. In order to develop a new vaccine for immunotherapy of atopic allergies, the major birch pollen allergen Bet v1 was fused to SbpA and the fusion protein recombinantly produced in B. subtilis (Ilk et al., 2011). Previous studies have shown the feasibility regarding immunomodulatory capacities of such vaccines but protein expression has always been carried out in E. coli, thus an additional, time-consuming endotoxin-removal step was required (Breitwieser et al., 2002; Ilk et al., 2002). In a recent study, the endotoxin-free fusion protein was secreted due to the amyQ signal peptide from Bacillus amyloliquefaciens and self-assembled but not crystallized in solution. Purification of the fusion protein from the culture medium was achieved by exploiting the specific binding mechanism between the N-terminus of SbpA and the secondary cell wall polymer – the natural anchor – in the peptidoglycan-containing sacculi of Ly. sphaericus (Ilk et al., 1999). The immune reactivity of the putative vaccine could be demonstrated in immunoblotting experiments with serum samples from patients suffering from birch pollen allergy (Ilk et al., 2011). SbpA has also been used, e.g. for the functional display of two copies of the IgG-binding domain Z of protein A from S. aureus (Völlenkle et al., 2004). The most commonly employed S-layer protein of Gram-negative bacterial origin is RsaA from Caulobacter crescentus. Despite being a Gram-negative host, the LPS structure of C. crescentus is quite unusual and less toxic compared with enteric bacteria (Smit et al., 2008). In one of the first studies it could be demonstrated that RsaA as a member of S-layer proteins can be employed for heterologous peptide display on bacterial cell surfaces (Bingle et al., 1997). Later, the IgG-binding domain of protein G was displayed as RsaA fusion in order to develop a low-cost antibody binding reagent (Nomellini et al., 2007). Recently, efforts have been undertaken to develop a RsaA based HIV-specific microbicide. The domain 1 of the HIV receptor and a ligand for the HIV co-receptor have been displayed on C. crescentus and when applied simultaneously showed additive microbicide effects and could effectively block infection in an HIV pseudovirus assay system (Nomellini et al., 2010).

Yeast cell display

Saccharomyces cerevisiae is the most frequently used eukaryotic display system, has GRAS status and can be cultivated to high cell densities in inexpensive media. There are two main display systems for yeast, the agglutinin system and the flocculin system. In most cases when applying the agglutinin system the protein of interest is fused to the C-terminus of Aga2, which is bound at the cell surface to Aga1 that is cell wall bound via a GPI anchor. Although the anchoring motif and the protein to be displayed are separated, the interaction of the two carrier proteins secures the surface display. The second version is employing α-agglutinin (Agα1). The protein of interest is fused between the signal sequence and the C-terminal half of Agα1, which contains the GPI anchor for cell wall binding (Kondo and Ueda, 2004). α-agglutinin has been used for, e.g. the display of the ZZ domain for IgG purification and immunoassays (Nakamura et al., 2001; Shimojo et al., 2004). S. cerevisiae allows the display of correctly folded eukaryotic proteins that failed in E. coli, e.g. a lot of allergens have conformational IgE epitopes that disappear in an incorrectly folded protein. Three components of the wasp venom (phospholipase A1, antigen 5, hyaluronidase) were tested for expression and surface display in S. cerevisiae using the Aga1/Aga2 system. All three fusion proteins were expressed and surface displayed but in various levels. Only antigen 5-expressing cells could be tested positive for allergen-specific histamine release from human cells and IgE binding as determined by FACS (Borodina et al., 2010). Several researchers also investigated the display of cohesins on the yeast surface: one anchor – Aga1/Aga2 for yeast display – will allow the display of a respective number of cohesins that will concomitantly bind a series of enzymes for the display of cellulosome-like structures, e.g. for the ethanol production based on cellulose (Tsai et al., 2009; Wen et al., 2010).

The flocculin system can also be applied following two different strategies. Either the GPI anchor of the C-terminal half of the FLO1 protein is used and as described for the Agα1 system, the protein of interest is fused between the signal sequence and the anchoring motif. A second approach employs the adhesive ability of the flocculation domain of FLO1, a fusion of this domain to the N-terminus of the protein of interest will non-covalently bind the heterologous fusion protein to the cell wall via interaction with mannan chains (Kondo and Ueda, 2004). The latter system has been suggested to be advantageous for the display of enzymes with a C-terminally located active site, e.g. lipases (Matsumoto et al., 2002) (Fig. 1).

image

Figure 1. Schematic overview of different display principles.

Download figure to PowerPoint

Endospores

  1. Top of page
  2. Summary
  3. Introduction
  4. Phage display
  5. Cell surface display
  6. Endospores
  7. Magnetosomes
  8. PHA granules
  9. References

Endospores are formed by members of the genera Bacillus and Clostridia to survive unfavourable conditions and nutrient depletion (Henriques and Moran, 2007) and are encapsulated in a protein shell or coat. In most cases this coat is the outermost spore structure, e.g. in B. subtilis, the most studied endospore forming organism (Driks, 1999). Of the at least 20 polypeptides of the coat some like CotA, CotB, CotC, CotF and CotG have been identified as surface proteins although in some cases the exact location remains still unclear (Isticato et al., 2001). So far, mainly CotB, CotC and CotG have been identified as suitable anchors. The first example of spore surface display used CotB as anchor and the C-terminal fragment of the tetanus toxin (TTFC), which has been used successfully before as model antigen (Medaglini et al., 2001). During this study, the 459 amino acid TTFC was fused to the N-terminus and the truncated C-terminus of CotB and also inserted into the middle of CotB. Flow cytometry confirmed the surface display of all three fusion proteins (Isticato et al., 2001). For further vaccine delivery studies only spores displaying the C-terminal CotB-TTFC fusion were used. Oral and intranasal immunization of mice provoked mucosal IgA and systemic IgG responses and confirmed the potential use of endospores displaying surface-expressed antigens as vaccine delivery vehicles (Kim and Schumann, 2009). TTFC has also been displayed as CotC fusion as well as the heat-labile toxin of E. coli, and again, both antigen-displaying spores showed positive immune responses in mice experiments (Mauriello et al., 2004). Low-cost production, heat stability and proven convenient oral delivery route of spore vaccines triggered thoughts of the ‘ideal’ strategy to use in developing countries and for military personnel (Duc et al., 2007). As the spore core itself is metabolically inactive (Henriques and Moran, 2000), mainly the spore surface layers are of biotechnological interest (Knurr et al., 2003; Dickinson et al., 2004) but gastrointestinal spore germination in connection with vaccination has also been investigated (Duc et al., 2003a,b; Hong et al., 2005). Duc et al. developed different application routes for spore based anthrax vaccines in contrast to the currently used acellular vaccine vehicles. The protective antigen (PA) was displayed as CotB or CotC fusion on the spore surface as well as overexpressed in the vegetative cell or germinated spore. Studies confirmed that the PA is only functional when secreted from the cell or displayed on the spore surface. N-terminally truncated forms of PA lacking the signal peptide could not confer protection against anthrax (Duc et al., 2007). Additionally, findings by the same group were showing that B. subtilis spores can germinate in the murine gut (Casula and Cutting, 2002; Duc et al., 2003a) and opened up a second way of application of spore based vaccines.

Two other coat proteins, CotG and CotE, have been used for the immobilization of β-galactosidase from E. coli, in both cases fused to the C-terminus of the anchor protein (Ban et al., 2003) and positive results indicated that the spore display systems might not be limited regarding size or multimeric nature of the target protein (Kim and Schumann, 2009).

The pathogens Bacillus cereus, Bacillus anthracis and Bacillus thuringiensis show an additional spore layer, the exosporium (Ricca and Cutting, 2003). Therefore, a different way of display has been explored, e.g. using the Bacillus thuringiensis protoxin as anchor for the display of GFP and scFv (Du et al., 2005). The protoxin is not essential for the functionality and integrity of the Bacillus thuringiensis spore, whereas the native as well as the functionalized Cot proteins are anchored to the Bacillus subtilis spore and part of the spore coat protein network (Kim et al., 2006; Kim and Schumann, 2009). GFP and β-galactosidase have also been fused to the C-terminal region of the Bacillus thuringiensis exosporium protein InhA (Park et al., 2009). Surface display and functionality could be confirmed and the authors proposed this method of display advantageous over the cot gene based method for the same reasons as Du et al.

Magnetosomes

  1. Top of page
  2. Summary
  3. Introduction
  4. Phage display
  5. Cell surface display
  6. Endospores
  7. Magnetosomes
  8. PHA granules
  9. References

Magnetosomes are intracellular crystal particles of magnetite, Fe3O4. These nanometre sized iron minerals are enveloped by a membrane and allow magnetotactic bacteria, e.g. Magnetospirillum magneticum and related bacteria, to migrate along magnetic field lines especially in oxygen gradients in aquatic environments (Blakemore, 1975). Magnetosome-specific genes are clustered in a so-called ‘magnetosome island’ in different species of magnetotactic bacteria. Mostly, magnetosome transmembrane proteins such as Mms13 and Mms16 are used as anchoring motifs for functional display of peptides, proteins, enzymes. Although Mms16 has been employed for functional display (Yoshino et al., 2004), there is evidence of its being only an artefact due to unspecific absorption during isolation as the mms16 gene is not located in the magnetosome island in the studied organism Magnetospirillum gryphiswaldense (Schultheiss et al., 2005). However, Mms13 could be shown to be tightly bound to the magnetite surface (Tanaka et al., 2006) and luciferase fusion protein studies demonstrated that the Mms13 C-terminus is localized to the magnetosome surface (Yoshino and Matsunaga, 2006). Magnetic cell separation using immunomagnetic particles is one of the routinely used current cell separation techniques and is considered simple, rapid and specific. Previously, MagA – a proton/iron ion antiporter protein (Nakamura et al., 1995) – has been used for the immobilization of the IgG binding domain ZZ from protein A (Kuhara et al., 2004). After identification of Mms13 as more suitable anchor protein, the experiments were repeated and Mms13 fusions performed significantly better (Matsunaga et al., 2006). Protein G was also displayed via Mms13 in M. magneticum AMB-1 and successfully used for the direct magnetic separation of immune cells from whole blood (Takahashi et al., 2009).

PHA granules

  1. Top of page
  2. Summary
  3. Introduction
  4. Phage display
  5. Cell surface display
  6. Endospores
  7. Magnetosomes
  8. PHA granules
  9. References

A wide variety of bacteria and even some archaea are able to form PHA inclusions as carbon and energy reserve material (Rehm, 2010). These inclusions are water-insoluble and spherical and often referred to as PHA granules (Rehm, 2006a). The key enzyme of the PHA granule formation is the PHA synthase, which catalyses the synthesis of PHA and mediates formation of intracellular PHA inclusions as well as it remains covalently bound i.e. immobilized to the surface of the emerging granule (Rehm, 2006b; 2007). PHA granules are not only surrounded by PHA synthase proteins but also various other proteins, which are non-covalently attached, such as, e.g. the structural proteins called phasins, PHA depolymerases or regulatory proteins (Grage et al., 2009). All these granule associated proteins were tested as suitable surface anchors for the immobilization of target proteins.

In one of the simplest approaches, the N-terminal granule-binding domain of the phasin PhaF from P. putida GPo1 was co-expressed with the protein of interest as functional fusion protein under PHA accumulating conditions. The anchoring domain – also called BioF – was employed as purification tag in analogy to other commercial protein tags and allowed purification of the protein of interest with the PHA granules as matrix material (Moldes et al., 2004). It is also possible using the whole phasin protein as anchoring sequence. In order to achieve higher purity of the isolated protein, inteins (intervening proteins) (Banki and Wood, 2005) were employed as linker sequences between a phasin and the protein of interest. The phasin, in most cases PhaP, allowed hydrophobic attachment to the natively formed granules inside the cells. For better binding to the PHA matrix, i.e. to reduce leakage, multiple copies of PhaP had to be used. The protein of interest could be purified using the self-cleaving intein linker. This system was developed for the natural host Ralstonia eutropha as well as in recombinant E. coli and is not necessarily combined with PHA granule isolation before protein purification and release (Banki et al., 2005; Barnard et al., 2005). Also, the production of PhaP-intein tagged fusion protein and PHA purification matrix can be separated from each other. The PHA matrix particles can also be made from already purified PHA. The crude extract containing the tagged protein of interest is incubated with the artificial PHA particles where phasin mediated binding followed by intein cleavage is leading to protein purification (Wang et al., 2008). A few years later, it was demonstrated that a single copy of PhaP is sufficient for extensive display of desired fusion proteins to native PHA granules. Also, the correct folding of eukaryotic proteins – here interleukin-2 and myelin oligodendrocyte glycoprotein – fused to PhaP and produced in E. coli could be shown in the first time FACS application of functionalized PHA granules (Bäckström et al., 2007). Interestingly, the N-terminus as well as the C-terminus of the anchoring PhaP can be used for functionalization without interference with PHA granule-binding (Bäckström et al., 2007), therefore even the display of two functionalities with the same PhaP anchor is possible as demonstrated in GFP-PhaP-myelin oligodendrocyte glycoprotein fusion protein displaying PHA granules (Atwood and Rehm, 2009).

In analogy to the BioF system described for phasins, the substrate binding domain of the PHA depolymerase from Alcaligenes faecalis was employed as protein purification tag for the enhanced green fluorescent protein (EGFP) and other reporter proteins (Lee et al., 2005). Although described as functional, other PHA displaying systems show wider applicability and are more exploited than the above-described depolymerase substrate binding domain system.

Only recently, the regulatory protein PhaR was described as affinity tag for protein purification. Again, an intein linker between PhaR and the target protein was employed for final release of the protein of interest, e.g. EGFP. The fusion protein production was hosted by recombinant E. coli, the PHA matrix nanoparticles were produced separately (Zhang et al., 2010). PhaP and PhaR fusions or parts thereof also found application in a transferable E. coli two-hybrid system. In short, the DNA-binding domain of PhaR is fused to the ‘bait’, the ‘prey’ is fused to PhaP. Upon formation of PHA granules, both fusion proteins will start interacting with each other, resulting in weaker interaction of the DNA-binding domain with its natural target the phaP promoter region. The resulting expression of the marker gene will directly indicate the interaction strength of ‘bait’ and ‘prey’ (Wang et al., 2011).

The most common PHA display system is based on the PHA synthase PhaC as surface anchor. While the above-described structural and regulatory proteins used as anchor proteins are non-covalently attached to the PHA surface, the synthase is covalently bound to the polyester core. Therefore, the displayed fusion protein is much more tightly connected to the support matrix. Most frequently, the target protein is fused to the N-terminus of the PHA synthase. Multiple examples show the diverse applicability of engineered PHA particles, e.g. the display of an α-amylase (Rasiah and Rehm, 2009), several variants of streptavidin (Peters and Rehm, 2008) or a scFv antibody (Grage and Rehm, 2008). The most successful application so far has been the display of the ZZ domain of protein A (Brockelbank et al., 2006). These engineered polyester particles performed equally compared with commercially available protein A beads and demonstrated the broad capacity of this display technology (Lewis and Rehm, 2009; Rehm et al., 2011). Until recently, proteins that needed a free C-terminal end for functionality could only be surface displayed on PHA particles using one of the non-covalently attached anchoring motifs. The lack of an engineering strategy for the synthase carboxy end could be overcome and thus the applicability of the whole technology broadened. Now, several functionalities can be displayed using the same anchoring motif – the PHA synthase – which allows the production of multifunctional PHA particles (Jahns and Rehm, 2009). So far this has only been possible by use of several anchoring motifs on the same particle surface or by use of the non-covalently attached phasin as mentioned above (Jahns et al., 2008; Atwood and Rehm, 2009). Efforts have been undertaken to also establish this recombinant protein production system in the Gram-positive host L. lactis to circumvent issues with pyrogen toxicity (Mifune et al., 2009).

Almost all display systems aim on applicability in biomedicine, as tools in bio-diagnostic assays and even more as vaccination vehicles. PHA particles applied for biomedical purposes are mostly artificially derived from isolated polyesters and fusion proteins are produced in endotoxin-free host organisms. This strategy led to the development of an endotoxin removal assay based on PhaP-tagged human LPS binding protein produced in Pichia pastoris (Li et al., 2011). To simulate targeted drug delivery, PHB-copolymer nanoparticles were loaded with a lipid-soluble dye to mimic the drug load and covered with recombinant PhaP-tagged human epidermal growth factor or mannosylated human α1-acid glycoprotein. Macrophages recognized the displayed proteins and receptor mediated endocytosis could be successfully established, proving the capacity of these particles for targeted drug release (Yao et al., 2008; Xiong et al., 2010). Vaccine vehicles based on PHA particles have been also developed, e.g. particles displaying a combined PhaC-tagged antigen from Mycobacterium tuberculosis could be successfully expressed in recombinant E. coli and displayed on in vivo produced PHA particles. Animal studies revealed no toxicity albeit the Gram-negative production host and immunological data unveiled a stronger response of the immobilized antigen compared with the free fusion protein alone (Parlane et al., 2009). These results were significant for the conception of polyester based vaccines as new emerging life science tools.

Although there are several functional display systems established in PHA research, some controversy occurs with respect to the method of PHA matrix production. Some groups prefer the in vitro production of PHA particles – pure PHB or co-polymers – and argue that the in vivo accumulation and isolation of fusion protein displaying particles would be a rather complicated and time-consuming process as mild and laborious methods have to be employed to prevent destruction and inhibition of the surface exposed functionality (Zhang et al., 2010). On the other hand, the in vitro formulation of PHA particles is frequently accumulating high amounts of solvent waste and depending on the application requires a laborious purification process. Successful examples also underline the merit of in vivo one-step production, especially when the PHA based immobilization is leading to the production of a target protein that is commonly known to form inclusion bodies as shown with the PhaP-tagged plasminogen activator (Geng et al., 2010). The authors explicitly stated the PHA particle based production of their protein as easy and efficient. One-step production also allows specific design and tailoring of the final product as demonstrated in the vaccine development without the obligation of additional steps like separate protein production, purification and conjugation or cross-linking (Parlane et al., 2009).

Lipid bodies

Neutral lipid inclusions are the major source of stored energy in eukaryotes. Triacylglycerols (TAGs) are stored as intracellular lipid droplets or lipid bodies (Murphy and Vance, 1999). These spherical structures serve as energy reserves and are essential for the intracellular energy metabolism and homeostasis (Bell and Coleman, 1980). In prokaryotes energy is mostly stored in PHA inclusions (see above). Nevertheless, some bacteria are also able to synthesize TAG inclusions (Alvarez and Steinbüchel, 2002). Structurally, bacterial and eukaryotic TAG inclusions are related: a neutral lipid matrix, composed of TAG or wax esters, is surrounded by a monolayer of phospholipids. Additionally, only eukaryotic lipid bodies show proteins embedded into the phospholipidlayer (Kalscheuer and Steinbüchel, 2003; Wältermann et al., 2005). Known eukaryotic lipid body associated proteins were heterologously expressed in prokaryotes able to synthesize TAG inclusions in order to study targeting and binding mechanisms. As these proteins successfully bound to prokaryotically derived lipid bodies it was hypothesized to employ heterologously expressed eukaryotic TAG binding proteins as surface anchors for biotechnological interesting applications of lipid inclusions displaying enzyme activities (Hänisch et al., 2006a). Already, the functionalization of bacterial TAG inclusions could be shown by employing the non-specific binding to lipid bodies of the PHA-binding phasin PhaP1 from R. eutropha H16 (Hänisch et al., 2006b). Fusion proteins comprising the EGFP or β-galactosidase could be functionally displayed on TAG inclusions using the PhaP1 anchor. Eukaryotic lipid bodies or lipid droplets are also investigated regarding functionality and targeting. In Drosophila studies the lipid droplet targeting domain of the Klar protein could be identified in the C-terminal region of the protein (Guo et al., 2005). A fusion of this previously identified domain to GFP was targeted to lipid droplets and allowed monitoring of lipid droplet formation and movement in living tissues of Drosophila (Yu et al., 2011).

References

  1. Top of page
  2. Summary
  3. Introduction
  4. Phage display
  5. Cell surface display
  6. Endospores
  7. Magnetosomes
  8. PHA granules
  9. References
  • Alvarez, H.M., and Steinbüchel, A. (2002) Triacylglycerols in prokaryotic microorganisms. Appl Microbiol Biotechnol 60: 367376.
  • Atwood, J.A., and Rehm, B.H.A. (2009) Protein engineering towards biotechnological production of bifunctional polyester beads. Biotechnol Lett 31: 131137.
  • Bäckström, B.T., Brockelbank, J.A., and Rehm, B.H.A. (2007) Recombinant Escherichia coli produces tailor-made biopolyester granules for applications in fluorescence activated cell sorting: functional display of the mouse interleukin-2 and myelin oligodendrocyte glycoprotein. BMC Biotechnology 7: 3.
  • Ban, J.G., Choi, S.G., Jung, H.C., Kim, B.G., and Kim, J.H. (2003) Method for expression of proteins on spore surface. KR 20030065534. South Korea. Patent.
  • Banki, M.R., and Wood, D.W. (2005) Inteins and affinity resin substitutes for protein purification and scale up. Microb Cell Fact 4: 32.
  • Banki, M.R., Gerngross, T.U., and Wood, D.W. (2005) Novel and economical purification of recombinant proteins: intein-mediated protein purification using in vivo polyhydroxybutryrate (PHB) matrix association. Protein Sci 14: 13871395.
  • Barnard, G.C., McCool, J.D., Wood, D.W., and Gerngross, T.U. (2005) Integrated recombinant protein expression and purification platform based on Ralstonia eutropha. Appl Environ Microbiol 71: 57355742.
  • Barr, S.M., Keck, K., and Aposhian, H.V. (1979) Cell-free assembly of a polyoma-like particle from empty capside and DNA. Virology 96: 656659.
  • Bastien, N., Trudel, M., and Simard, C. (1997) Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus. Virology 234: 118122.
  • Bell, R.M., and Coleman, R.A. (1980) Enzymes of glycerolipid synthesis in eukaryotes. Annu Rev Biochem 49: 459487.
  • Benhar, I. (2001) Biotechnological applications of phage and cell display. Biotechnol Adv 19: 133.
  • Bingle, W.H., Nomellini, J.F., and Smit, J. (1997) Cell-surface display of a Pseudomonas aeruginosa strain K pilin peptide within the paracrystalline S-layer of Caulobacter crescentus. Mol Microbiol 26: 277288.
  • Blakemore, R.P. (1975) Magnetotactic bacteria. Science 190: 377379.
  • Blasi, U., Linke, R.P., and Lubitz, W. (1989) Evidence for membrane-bound oligomerization of bacteriophage ΦX174 lysis protein E. J Biol Chem 264: 45524558.
  • Borodina, I., Jensen, B.M., Søndergaard, I., and Poulsen, L.K. (2010) Display of wasp venom allergens on the cell surface of Saccharomyces cerevisiae. Microb Cell Fact 9: 74.
  • Braun, H., Boller, K., Lower, J., Bertling, W.M., and Zimmer, A. (1999) Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coli. Biotechnol Appl Biochem 29: 3143.
  • Breitwieser, A., Egelseer, E.M., Moll, D., Ilk, N., Hotzy, C., Bohle, B., et al. (2002) A recombinant bacterial cell surface (S-layer)-major birch pollen allergen-fusion protein (rSbsC/ Bet v1) maintains the ability to self-assemble into regularly structured monomolecular lattices and the functionality of the allergen. Protein Eng 15: 243249.
  • Bright, R.A., Carter, D.M., Crevar, C.J., Toapanta, F.R., Steckbeck, J.D., Cole, K.S., et al. (2008) Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 1: e1501.
  • Brockelbank, J.A., Peters, V., and Rehm, B.H.A. (2006) Recombinant Escherichia coli strain produces a ZZ domain displaying biopolyester granules suitable for immunoglobulin G purification. Appl Environ Microbiol 72: 73947397.
  • Bruttin, A., and Brussow, H. (2005) Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 49: 28742878.
  • Cai, K., Gao, X., Li, T., Hou, X., Wang, Q., Liu, H., et al. (2010) Intragastric immunization of mice with enterohemorrhagic Escherichia coli O157:H7 bacterial ghosts reduces mortality and shedding and induces a Th2-type dominated mixed immune response. Can J Microbiol 56: 389398.
  • Calabi, E., Ward, S., Wren, B., Paxton, T., Panico, M., Morris, H., et al. (2001) Molecular characterization of the surface layer proteins from Clostridium difficile. Mol Microbiol 40: 11871199.
  • Casula, G., and Cutting, S.M. (2002) Bacillus probiotics: spore germination in the gastrointestinal tract. Appl Environ Microbiol 68: 23442352.
  • Charbit, A., Boulain, J.C., Ryter, A., and Hofnung, M. (1986) Probing the topology of a bacterial membrane protein by genetic insertion of a foreign epitope; expression at the cell surface. EMBO J 5: 30293037.
  • Chen, W., and Georgiou, G. (2002) Cell-surface display of heterologous proteins: From high-throughput screening to environmental applications. Biotechnol Bioeng 79: 496503.
  • Clark, J.R., and March, J.B. (2006) Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol 24: 212218.
  • Deutscher, S.L. (2010) Phage display in molecular imaging and diagnosis of cancer. Chem Rev 110: 31963211.
  • Dickerson, T.J., Kaufmann, G.F., and Janda, K.D. (2005) Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy. Expert Opin Biol Ther 5: 773781.
  • Dickinson, D.N., La Duc, M.T., Haskins, W.E., Gornushkin, I., Winefordner, J.D., Powell, D.H., et al. (2004) Species differentiation of a diverse suite of Bacillus spores by mass spectrometry-based protein profiling. Appl Environ Microbiol 70: 475482.
  • Driks, A. (1999) Bacillus subtilis spore coat. Microbiol Mol Biol Rev 63: 120.
  • Du, C., Chan, W.C., McKeithan, T.W., and Nickerson, K.W. (2005) Surface display of recombinant proteins on Bacillus thuringiensis spores. Appl Environ Microbiol 71: 33373341.
  • Duc, L.H., Hong, H.A., and Cutting, S.M. (2003a) Germination of the spore in the gastrointestinal tract provides a novel route for heterologous antigen delivery. Vaccine 21: 42154224.
  • Duc, L.H., Hong, H.A., Fairweather, N., Ricca, E., and Cutting, S.M. (2003b) Bacterial spores as vaccine vehicles. Infect Immun 71: 28102818.
  • Duc, L.H., Hong, H.A., Atkins, H.S., Flick-Smith, H.C., Durrani, Z., Rijpkema, S., et al. (2007) Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen. Vaccine 25: 346355.
  • Ebensen, T., Paukner, S., Link, C., Kudela, P., de Domenico, C., Lubitz, W., et al. (2004) Bacterial ghosts are an efficient delivery system for DNA vaccines. J Immunol 172: 68586865.
  • Eko, F.O., Mayr, U.B., Attridge, S.R., and Lubitz, W. (2000) Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili. J Biotechnol 83: 115123.
  • Eko, F.O., Lubitz, W., McMillan, L., Ramey, K., Moore, T.T., Ananaba, G.A., et al. (2003a) Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Vaccine 21: 16941703.
  • Eko, F.O., Schukovskaya, T., Lotzmanova, E.Y., Fistova, V.V., Emalyanova, N.V., Klueva, S.N., et al. (2003b) Evaluation of the protective efficacy of Vibrio cholerae ghosts (VCG) candidate vaccines in rabbits. Vaccine 21: 36633674.
  • Engelhardt, H., and Peters, J. (1998) Structural research on surface layers: a focus on stability, surface layer homology domains, and surface layer-cell wall interaction. J Struct Biol 124: 276302.
  • Francisco, J.A., and Georgiou, G. (1994) The expression of recombinant proteins on the external surface of Escherichia coli. Biotechnological Applications. Ann NY Acad Sci 745: 372382.
  • Francisco, J.A., Earhart, C.F., and Georgiou, G. (1992) Transport and anchoring of beta-lactamase to the external surface of Escherichia coli. Proc Natl Acad Sci USA 89: 27132718.
  • Freudl, R., MacIntyre, S., Degen, M., and Henning, U. (1986) Cell surface exposure of the outer membrane protein OmpA of Escherichia coli K-12. J Mol Biol 188: 491494.
  • Fu, L.L., Xu, Z.R., Li, W.F., Shuai, J.B., Lu, P., and Hu, C.X. (2006) Protein secretion pathways in Bacillus subtilis. Implication for optimization of heterologous protein secretion. Biotechnol Adv 25: 112.
  • Funatsu, T., Taniyama, T., Tajima, T., Tadakuna, H., and Namiki, H. (2002) Rapid and sensitive detection method of a bacterium by using a GFP reporter phage. Microbiol Immunol 46: 365369.
  • Gao, J., Wang, Y., Liu, Z., and Wang, Z. (2010) Phage display and its application in vaccine design. Ann Microbiol 60: 1319.
  • Garcea, R.L., and Gissmann, L. (2004) Virus-like particles as vaccines and vessels for the delivery of small molecules. Curr Opin Biotechnol 15: 513517.
  • Gaubin, M., Fanutti, C., Mishal, Z., Durrbach, A., De Berardinis, P., Sartorius, R., et al. (2003) Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments. DNA Cell Biol 22: 1118.
  • Geng, Y., Wang, S., and Qi, Q. (2010) Expression of active recombinant human tissue-type plasminogen activator by using in vivo polyhydroxybutyrate granule display. Appl Environ Microbiol 76: 72267230.
  • Gleiter, S., and Lilie, H. (2001) Coupling of antibodies via protein Z on modified polyoma virus-like particles. Protein Sci 10: 434444.
  • Gleiter, S., and Lilie, H. (2003) Cell-type specific targeting and gene expression using a variant of polyoma VP1 virus-like particles. Biol Chem 384: 247255.
  • Goodridge, L., Chen, J., and Griffiths, M. (1999) Development and characterization of a fluorescent-bacteriophage assay for detection of Escherichia coli O157:H7. Appl Environ Microbiol 65: 13971404.
  • Grage, K., and Rehm, B.H.A. (2008) In vivo production of scFv-displaying biopolymer beads using a self-assembly-promoting fusion partner. Bioconjug Chem 19: 254262.
  • Grage, K., Jahns, A.C., Parlane, N., Palanisamy, R., Rasiah, I.A., Atwood, J.A., et al. (2009) Bacterial polyhydroxyalkanoate granules: biogenesis, structure and potential use as micro-/nano-beads in biotechnological and biomedical applications. Biomacromolecules 10: 660669.
  • Guo, Y., Jangi, S., and Welte, M.A. (2005) Organelle-specific control of intracellular transport: distinctly targeted isoforms of the regulator Klar. Mol Biol Cell 16: 14061416.
  • Haidinger, W., Mayr, U.B., Szostak, M.P., Resch, S., and Lubitz, W. (2003) Escherichia coli ghost production by expression of lysis gene E and staphylococcal nuclease. Appl Environ Microbiol 69: 61066113.
  • Hänisch, J., Wältermann, M., Robenek, H., and Steinbüchel, A. (2006a) Eukaryotic lipid body proteins in oleogenous actinomycetes and their targeting to intracellular triacylglycerol inclusions: impact on models of lipid body biogenesis. Appl Environ Microbiol 72: 67436750.
  • Hänisch, J., Wältermann, M., Robenek, H., and Steinbüchel, A. (2006b) The Ralstonia eutropha H16 phasin PhaP1 is targeted to intracellular triacylglycerol inclusions in Rhodococcus opacus PD630 and Mycobacterium smegmatis mc2155, and provides an anchor to target other proteins. Microbiology 152: 32713280.
  • Haslberger, A.G., Kohl, G., Felnerova, D., Mayr, U.B., Fürst-Ladani, S., and Lubitz, W. (2000) Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells. J Biotechnol 83: 5766.
  • Henke, S., Rohmann, A., Bertling, W.M., Dingermann, T., and Zimmer, A. (2000) Enhanced in vitro oligonucleotide and plasmid DNA transport by VP1 virus-like particles. Pharm Res 17: 10621070.
  • Henriques, A.O., and Moran, C.P., Jr (2000) Structure and assembly of the bacterial endospore coat. Methods 20: 95110.
  • Henriques, A.O., and Moran, C.P., Jr (2007) Structure, assembly, and function of the spore surface layers. Annu Rev Microbiol 61: 555588.
  • Hong, H.A., Duc, L.H., and Cutting, S.M. (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29: 813835.
  • Hoogenboom, H.R., de Bruine, A.P., Hufton, S.E., Hoet, R.M., Arends, J.W., and Roovers, R.C. (1998) Antibody phage display technology and its applications. Immunotechnology 4: 120.
  • Ilk, N., Kosna, P., Puchberger, M., Egelseer, E.M., Mayer, H.F., Sleytr, U.B., et al. (1999) Structural and functional analyses of the secondary cell wall polymer of Bacillus sphaericus CCM 2177 that serves as an S-layer-specific anchor. J Bacteriol 181: 76437646.
  • Ilk, N., Völlenkle, C., Egelseer, E.M., Breitwieser, A., Sleytr, U.B., and Sará, M. (2002) Molecular characterization of the S-layer gene, sbpA, of Bacillus sphaericus CCM 2177 and production of a functional S-layer fusion protein with the ability to recrystallize in a defined orientation while presenting the fused allergen. Appl Environ Microbiol 68: 32513260.
  • Ilk, N., Schumi, C.T., Bohle, B., Egelseer, E.M., and Sleytr, U.B. (2011) Expression of an endotoxin-free S-layer/allergen fusion protein in gram-positive Bacillus subtilis 1012 for the potential application as vaccines for immunotherapy of atopic allergy. Microb Cell Fact 10: 6.
  • Isticato, R., Cangiano, G., Tran, H.T., Ciabattini, A., Medaglini, D., Oggioni, M.R., et al. (2001) Surface display of recombinant proteins on Bacillus subtilis spores. J Bacteriol 183: 62946301.
  • Jahns, A.C., and Rehm, B.H.A. (2009) Tolerance of the Ralstonia eutropha class I polyhydroxyalkanoate synthase for translational fusions to its C terminus reveals a new mode of functional display. Appl Environ Microbiol 75: 54615466.
  • Jahns, A.C., Haverkamp, R.G., and Rehm, B.H.A. (2008) Multifunctional inorganic-binding beads self-assembled inside engineered bacteria. Bioconjug Chem 19: 20722080.
  • Jalava, K., Hensel, A., Szostak, M., Resch, S., and Lubitz, W. (2002) Bacterial ghosts as vaccine candidates for veterinary applications. J Control Release 85: 1725.
  • Jalava, K., Eko, F.O., Riedmann, E., and Lubitz, W. (2003) Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery. Expert Rev Vaccines 2: 4551.
  • Jechlinger, W., Azimpour Tabrizi, C., Lubitz, W., and Mayrhofer, P. (2004) Mini-circle DNA immobilized in Escherichia coli ghosts: A novel DNA delivery system. J Microbiol Biotechnol 8: 222231.
  • Jung, H.C., Lebeault, J.M., and Pan, J.G. (1998) Surface display of Zymomonas mobilis levansucrase by using the ice-nucleation protein of Pseudomonas syringae. Nat Biotechnol 16: 576580.
  • Jung, H.C., Kwon, S.K., and Pan, J.G. (2006) Display of a thermostable lipase on the surface of a solvent-resistant bacterium, Pseudomonas putida GM730, and its applications in whole-cell biocatalysis. BMC Biotechnology 6: 23.
  • Kalscheuer, R., and Steinbüchel, A. (2003) A novel bifunctional wax ester synthase/acyl-CoA:diacylglycerol acyltransferase mediates wax ester and triacylglycerol biosynthesis in Acinetobacter calcoaceticus ADP1. J Biol Chem 287: 80758082.
  • Kim, J., and Schumann, W. (2009) Display of proteins on Bacillus subtilis endospores. Cell Mol Life Sci 66: 31273136.
  • Kim, M., Hahn, M., Grabowski, P., McPherson, D.C., Otte, M.M., Wang, R., et al. (2006) The Bacillus subtilis spore coat protein interaction network. Mol Microbiol 59: 487502.
  • Knurr, J., Benedek, O., Heslop, J., Vinson, R.B., Boydston, J.A., McAndrew, J., et al. (2003) Peptide ligands that bind selectively to spores of Bacillus subtilis and closely related species. Appl Environ Microbiol 69: 68416847.
  • Kodikara, C.P., Crew, H.H., and Stewart, G.S.A.B. (1991) Near on-line detection of enteric bacteria using lux recombinant bacteriophage. FEMS Microbiol Lett 67: 261265.
  • Kondo, A., and Ueda, M. (2004) Yeast cell-surface display – applications of molecular display. Appl Microbiol Biotechnol 64: 2840.
  • Koutsky, L.A., Ault, K.A., Wheeler, C.M., Brown, D.R., Barr, E., Alvarez, F.B., et al. (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347: 16451651.
  • Kronqvist, N., Löfblom, J., Jonssen, A., Wernérus, H., and Ståhl, S. (2008) A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry. Protein Eng Des Sel 21: 247255.
  • Kuhara, M., Takeyama, H., Tanaka, T., and Matsunaga, T. (2004) Magnetic cell separation using antibody binding with protein A expressed on bacterial magnetic particles. Anal Chem 76: 62076213.
  • Kuwajima, G., Asaka, J.I., Fujiwara, T., Fujiwara, T., Nakamo, K., and Kondoh, E. (1988) Presentation of an antigenic determinant from hen egg-white lysozyme on the flagellar filament of Escherichia coli. Bio/Technology 6: 10801083.
  • Lee, S.J., Park, J.P., Park, T.J., Lee, S.Y., Lee, S., and Park, J.K. (2005) Selective immobilization of fusion proteins on poly(hydroxyalkanoate) microbeads. Anal Chem 77: 57555759.
  • Lenz, P., Day, P.M., Pang, Y.Y., Trye, S.A., Jensen, P.N., Lowy, D.R., et al. (2001) Papillomavirus-like particles induce acute activation of dendritic cells. J Immunol 166: 53465355.
  • Lewis, J.G., and Rehm, B.H.A. (2009) ZZ polyester beads: an efficient and simple method for purifying IgG from mouse hybridoma supernatants. J Immunol Methods 346: 7174.
  • Li, J., Shang, G., You, M., Peng, S., Wang, Z., Wu, H., et al. (2011) Endotoxin removing method based on lipopolysaccharide binding protein and polyhydroxyalkanoate binding protein PhaP. Biomacromolecules 12: 602608.
  • Li, L., Kang, D.G., and Cha, H.J. (2003) Functional display of foreign protein on surface of Escherichia coli using N-terminal domain of ice nucleation protein. Biotechnol Bioeng 85: 214221.
  • Lu, Z., Murray, K.S., Cleave, V.V., LaVallie, E.R., Ståhl, M.L., and McCoy, J.M. (1995) Expression of thioredoxin random peptide libraries on the Escherichia coli surface as functional fusions to flagellin: a system designed for exploring protein-protein interactions. Bio/Technology 13: 366372.
  • Lubitz, P., Mayr, U.B., and Lubitz, W. (2009) Applications of bacterial ghosts in biomedicine. Adv Exp Med Biol 655: 159170.
  • Lubitz, W., Halfmann, G., and Plapp, R. (1984) Lysis of Escherichia coli after infection with ΦX174 depends on the regulation of the cellular autolytic system. J Gen Microbiol 130: 10791087.
  • McCaffterty, J., Griffiths, A.D., Winter, G., and Chiswell, D.J. (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348: 552554.
  • Mader, H.J., Szostak, M.P., Hensel, A., Lubitz, W., and Haslberger, A.G. (1997) Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines. Vaccine 15: 195202.
  • Matsumoto, T., Fukuda, H., Ueda, M., Tanaka, A., and Kondo, A. (2002) Construction of yeast strains with high cell surface lipase activity by using novel display systems based on the Flo1p flocculation functional domain. Appl Environ Microbiol 68: 45174522.
  • Matsunaga, T., Takahashi, M., Yoshino, T., Kuhara, M., and Takeyama, H. (2006) Magnetic separation of CD14+ cells using antibody binding with Protein A expressed on bacterial magnetic particles for generating dendritic cells. Biochem Biophys Res Commun 350: 10191025.
  • Mauriello, E.M., Duc, L.H., Isticato, R., Cangiano, G., Hong, H.A., De, F.M., et al. (2004) Display of heterologous antigens on the Bacillus subtilis spore coat usingn CotC as a fusion partner. Vaccine 22: 11771187.
  • May, T., Gleiter, S., and Lilie, H. (2002) Assessment of cell type specific gene transfer of polyoma virus like particles presenting a tumor specific antibody Fv fragment. J Virol Methods 105: 147157.
  • Mayr, U.B., Haller, C., Haidinger, W., Atrashenskaya, A., Bukin, E., Lubitz, W., et al. (2005) Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 baacterial ghosts protects mice against lethal challenge. Infect Immun 73: 48104817.
  • Mayrhofer, P., Azimpour Tabrizi, C., Walcher, P., Haidinger, W., Jechlinger, W., and Lubitz, W. (2005) Immobilization of plasmid DNA in bacterial ghosts. J Control Release 102: 725735.
  • Medaglini, D., Ciabattini, A., Spinosa, M.R., Maggi, T., Marcotte, H., Oggioni, M.R., et al. (2001) Immunization with recombinant Streptococcus gardinii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 19: 19311939.
  • Mifune, J., Grage, K., and Rehm, B.H.A. (2009) Production of functionalized biopolyester granules by recombinant Lactococcus lactis. Appl Environ Microbiol 75: 46684675.
  • Mobili, P., Gerbino, E., Tymczyszyn, E.E., and Gómez-Zavaglia, A. (2010) S-layers in lactobacilli: structural characteristics and putative role in surface and probiotic properties of whole bacteria. In Currrent Research, Technology and Education Topics in Applied Microbiology and Microbial Biotechnology. Méndez-Vilas, A. (ed.). Badajoz, Spain: Formatex Research Center, pp. 12241234.
  • Moldes, C., Garcia, P., Garcia, J.L., and Prieto, M.A. (2004) In vivo immobilization of fusion proteins on bioplastics by the novel tag BioF. Appl Environ Microbiol 70: 32053212.
  • Murphy, D.J., and Vance, J. (1999) Mechanisms of lipid-body formation. Trends Biochem Sci 24: 109115.
  • Nakamura, C., Burgess, J.G., Sode, K., and Matsunaga, T. (1995) An iron-regulated gene, magA, encoding an iron transport protein of Magnetospirillum sp. strain AMB-1. J Biol Chem 270: 2839228396.
  • Nakamura, Y., Shibasaki, S., Ueda, M., Tanaka, A., Fukuda, H., and Kondo, A. (2001) Development of novel whole-cell immunoadsorbents by yeast surface display of the IgG-binding domain. Appl Microbiol Biotechnol 57: 500505.
  • Nomellini, J.F., Duncan, G., Dorocicz, I.R., and Smit, J. (2007) S-layer-mediated display of the immunoglobulin G-binding domain of streptococcal protein G on the surface of Caulobacter crescentus: development of an immunoactive reagent. Appl Environ Microbiol 73: 32453253.
  • Nomellini, J.F., Li, C., Lavallee, D., Shanina, I., Cavacini, L.A., Horwitz, M.S., et al. (2010) Development of an HIV-1 specific microbicide using Caulobacter crescentus S-layer mediated display of CD4 and MIP1α. PLoS ONE 5: e10366.
  • Park, T.J., Choi, S.K., Jung, H.C., Lee, S.Y., and Pan, J.G. (2009) Spore display using Bacillus thuringiensis exosporium protein InhA. J Microbiol Biotechnol 19: 495510.
  • Parlane, N., Wedlock, D.N., Buddle, B.M., and Rehm, B.H.A. (2009) Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents. Appl Environ Microbiol 75: 77397744.
  • Parmley, S.F., and Smith, G.P. (1988) Antibody-selectable filamentous fd phage vector-affinity purification of target genes. Gene 73: 305318.
  • Paukner, S., Kudela, P., Kohl, G., Schapp, T., Friedrichs, S., and Lubitz, W. (2005) DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages. Mol Ther 11: 215223.
  • Peters, V., and Rehm, B.H.A. (2008) Protein engineering of streptavidin for in vivo assembly of streptavidin beads. J Biotechnol 134: 266274.
  • Petry, H., Goldmann, C., Ast, O., and Luke, W. (2003) The use of virus-like particles for gene transfer. Curr Opin Mol Ther 5: 524528.
  • Rakonjac, J., Bennett, N.J., Spagnuolo, J., Gagic, D., and Russel, M. (2010) Filamentous bacteriophage: biology, phage display and nanotechnology applications. Curr Issues Mol Biol 13: 5176.
  • Rasiah, I.A., and Rehm, B.H.A. (2009) One-step production of immobilized α-amylase in recombinant Escherichia coli. Appl Environ Microbiol 75: 20122016.
  • Rehm, B.H.A. (2006a) Biogenesis of microbial polyhydroxyalkanoate granules: a platform technology for the production of tailor-made bioparticles. Curr Issues Mol Biol 9: 4162.
  • Rehm, B.H.A. (2006b) Genetics and biochemistry of polyhydroxyalkanoate granule self-assembly: the key role of polyester synthases. Biotechnol Lett 28: 207213.
  • Rehm, B.H.A. (2007) Biogenesis of Microbial Polyhydroxyalkanoate Granules: a Platform Technology for the Production of Tailor-made Bioparticles. Curr Issues Mol Biol 9: 4162.
  • Rehm, B.H.A. (2010) Bacterial polymers: biosynthesis, modifications and applications. Nat Rev Microbiol 8: 578592.
  • Rehm, B.H.A., Thompson, T., and Plassmeyer, M. (2011) Bioengineered protein A polymer beads for high-affinity antibody purification. BioPharm Int 24: 3642.
  • Ricca, E., and Cutting, S.M. (2003) Emerging applications of bacterial spores in nanobiotechnology. J Nanobiotechnology 1: 6.
  • Ross, T.M., Mahmood, K., Crevar, C.J., Schneider-Ohrum, K., Heaton, P.M., and Bright, R.A. (2009) A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. PLoS ONE 4: e6032.
  • Rudolf, M.P., Fausch, S.C., DaSilva, D.M., and Kast, W.M. (2001) Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro. J Immunol 166: 59175924.
  • Rutherford, N., and Mourez, M. (2006) Surface display of proteins by Gram-negative bacterial autotransporters. Microb Cell Fact 5: 22.
  • Samuelson, P., Wernérus, H., Svedberg, M., and Ståhl, S. (2000) Staphylococcal surface display of metal-binding polyhistidyl peptides. Appl Environ Microbiol 66: 12431248.
  • Samuelson, P., Gunneriusson, E., Nygren, P.A., and Ståhl, S. (2002) Display of proteins on bacteria. J Biotechnol 96: 129154.
  • Schneewind, O., Mihaylova-Petkov, D., and Model, P. (1993) Cell wall sorting signals in surface proteins of Gram-positive bacteria. EMBO J 12: 48034811.
  • Schneewind, O., Fowler, A., and Faull, K.F. (1995) Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science 268: 103106.
  • Schultheiss, D., Handrick, R., Jendrossek, D., Hanzlik, M., and Schüler, D. (2005) The presumptive magnetosome protein Mms16 is a poly(3-hydroxybutyrate) granule-bound protein (phasin) in Magnetospirillum gryphiswaldense. J Bacteriol 187: 24162425.
  • Shao, X., Jiang, M., Yu, Z., Cai, H., and Li, L. (2009) Surface display of heterologous proteins in Bacillus thuringiensis using a peptidoglycan hydrolase anchor. Microb Cell Fact 8: 48.
  • Shimazu, M., Mulchandani, A., and Chen, W. (2001) Cell surface display of organophosphorus hydrolase using ice nucleation protein. Biotechnol Prog 17: 7680.
  • Shimojo, R., Furukawa, H., Fukuda, H., and Kondo, A. (2004) Preparation of yeast strains displaying IgG binding domain ZZ and EGFP for novel antigen detection system. J Biosci Bioeng 96: 493495.
  • Sleytr, U.B., and Beveridge, T.J. (1999) Bacterial S-layers: structure, function relationships and their biotechnological applications. Trends Microbiol 7: 253260.
  • Sleytr, U.B., Egelseer, E., Ilk, N., Pum, D., and Schuster, B. (2007a) S-layers as a basic building block in a molecular construction kit. FEBS J 274: 323334.
  • Sleytr, U.B., Huber, C., Ilk, N., Pum, D., Schuster, B., and Egelseer, E. (2007b) S-layers as a tool kit for nanobiotechnological applications. FEMS Microbiol Lett 267: 131144.
  • Smit, J., Kaltashov, I.A., Cotter, R.J., Vinogradov, E., Perry, M.B., Haider, H., et al. (2008) Structure of a novel lipid A obtained from the lipopolysaccharide of Caulobacter crescentus. Innate Immun 14: 2536.
  • Smith, G.P. (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228: 13151317.
  • Ståhl, S., and Uhlén, M. (1997) Bacterial surface display: trends and progress. Trends Biotechnol 15: 185192.
  • Steidler, L., Viaene, J., Fiers, W., and Remaut, E. (1998) Functional display of a heterologous protein on the surface of Lactococcus lactis by means of the cell wall anchor of Stpaphylococcus aureus protein A. Appl Environ Microbiol 64: 342345.
  • Strauss, A., and Götz, F. (1996) In vivo immobilization of enzymatically active polypeptides on the cell surface of Staphylococcus carnosus. Mol Microbiol 21: 491500.
  • Szécsi, J., Boson, B., Johnsson, P., Dupeyrot-Lacas, P., Matrosovich, M., Klenk, H.D., et al. (2006) Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses. Virol J 3: 70.
  • Szostak, M.P., Hensel, A., Eko, F.O., Klein, R., Auer, T., Mader, H., et al. (1996) Bacterial ghosts: non-living candidate vaccines. J Biotechnol 44: 161170.
  • Takahashi, M., Yoshino, T., Takeyama, H., and Matsunaga, T. (2009) Direct magnetic separation of immune cells from whole blood using bacterial magnetic particles displaying protein G. Biotechnol Prog 25: 219226.
  • Tanaka, M., Okamura, Y., Arakaki, A., Tanaka, T., Takeyama, H., and Matsunaga, T. (2006) Origin of magnetosome membrane: proteomic analysis of magnetosome membrane and comparison with cytoplasmic membrane. Proteomics 6: 52345247.
  • Tsai, S.L., Oh, J., Singh, S., Chen, R., and Chen, W. (2009) Functional assembly of minicellulosomes on the Saccharomyces cerevisiae cell surface for cellulose hydrolysis and ethanol production. Appl Environ Microbiol 75: 60876093.
  • Völlenkle, C., Weigert, S., Ilk, N., Egelseer, E., Weber, V., Loth, F., et al. (2004) Construction of a functional S-layer fusion protein comprising an immunoglobulin G-binding domain for development of specific adsorbents for extra-corporeal blood purification. Appl Environ Microbiol 70: 15141521.
  • Wältermann, M., Hinz, A., Robenek, H., Troyer, D., Reichelt, R., Malkus, U., et al. (2005) Mechanism of lipid-body formation in prokaryotes: How bacteria fatten up. Mol Microbiol 55: 750763.
  • Wang, Z., Wu, H., Chen, J., Zhang, J., Yao, Y., and Chen, G.Q. (2008) A novel self-cleaving phasing tag for purification of recombinant proteins based on hydrophobic polyhydroxyalkanoate nanoparticles. Lab Chip 8: 19571962.
  • Wang, Z.H., Ma, P., Chen, J., Zhang, J., Chen, C.B., and Chen, G.Q. (2011) A transferable heterogeneous two-hybrid system in Escherichia coli based on polyhydroxyalkanoates synthesis regulatory protein PhaR. Microb Cell Fact 10: 21.
  • Warfield, K.L., Bosio, C.M., Welcher, B.C., Deal, E.M., Mohamadzadeh, M., Schmaljohn, A., et al. (2003) Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci USA 100: 1588915894.
  • Watson, B.B., and Eveland, W.C. (1965) The application of the phage-fluorescent antiphage staining system in the specific identification of Listeria monocytogenes. I. Species specificity and immunofluorescnet sensitivity of Listeria monocytogenes phage observed in smear preparations. J Infect Dis 115: 363369.
  • Wen, F., Sun, J., and Zhao, H. (2010) Yeast surface display of trifunctional minicellulosomes for simultaneous saccharification and fermentation of cellulose to ethanol. Appl Environ Microbiol 76: 12511260.
  • Wernérus, H., Leliziö, J., Teeri, T., Nygren, P.A., and Ståhl, S. (2001) Generation of metal-binding staphylococci through surface display of combinatorially engineered cellulose-binding domains. Appl Environ Microbiol 67: 46784684.
  • Wieczorek, A.S., and Martin, V.J.J. (2010) Engineering the cell surface display of cohesins for assembly of cellulosome-inspired enzyme complexes on Lactococcus lactis. Microb Cell Fact 9: 69.
  • Wilson, D.R., and Beveridge, T.J. (1993) Bacterial flagellar filaments and their component flagellin. Can J Microbiol 39: 451472.
  • Winter, G., Griffiths, A.D., Hawkins, R.E., and Hoogenboom, H.R. (1994) Making antibodies by phage display technology. Annu Rev Immunol 12: 433455.
  • Witte, A., Blasi, U., Halfmann, G., Szostak, M., Wanner, G., and Lubitz, W. (1990) ΦX174 protein E-mediated lysis of Escherichia coli. Biochimie 72: 191200.
  • Witte, A., Wanner, G., Sulzner, M., and Lubitz, W. (1992) Dynamics of ΦX174 protein E-mediated lysis of Escherichia coli. Arch Microbiol 157: 381388.
  • Wu, C.Y., Yeh, Y.C., Yang, Y.C., Chou, C., Liu, M.T., Wu, H.S., et al. (2010) Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus. PLoS ONE 5: e9784.
  • Xiong, Y.C., Yao, Y.C., Zhan, X.Y., and Chen, G.Q. (2010) Application of polyhydroxyalkanoates nanoparticles as intracellular sustained drug-release vectors. J Biomater Sci Polym Ed 21: 127140.
  • Yao, Y.C., Zhan, X.Y., Zhang, J., Zou, X.H., Wang, Z.H., Xiong, Y.C., et al. (2008) A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands. Biomaterials 29: 48234830.
  • Yoshino, T., and Matsunaga, T. (2006) Efficient and stable display of functional proteins on bacterial magnetic particles using Mms13 as a novel anchor molecule. Appl Environ Microbiol 72: 465471.
  • Yoshino, T., Takahashi, M., Takeyama, H., Okamura, Y., Kato, F., and Matsunaga, T. (2004) Assembly of G protein-coupled receptors onto nanosized bacterial magnetic particles using Mms16 as an anchor molecule. Appl Environ Microbiol 70: 28802885.
  • Yu, Y.V., Li, Z., Rizzo, N.P., Einstein, J., and Welte, M.A. (2011) Targeting the motor regulator Klar to lipid droplets. BMC Cell Biology 12: 9.
  • Zhang, S., Wang, Z.H., and Chen, G.Q. (2010) Microbial polyhydroxyalkanoate synthesis regression protein PhaR as an affinity tag for recombinant protein purification. Microb Cell Fact 9: 28.
  • Zuercher, A.W., Miescher, S.M., Vogel, M., Rudolf, M.P., Stadler, M.B., and Stadler, B.M. (2000) Oral anti-IgE immunization with epitope-displaying phage. Eur J Immunol 30: 128135.